Overview
ICOPAN-DSR is a high-efficacy, dual-action gastrointestinal formulation designed to manage acid-related disorders. Combining Pantoprazole (40mg) as gastro-resistant pellets and Domperidone (30mg) as prolonged-release pellets, this medication offers a balanced approach to acid suppression and motility management. Marketed by Icon Medilabs, ICOPAN-DSR is manufactured to exacting pharmaceutical standards to ensure therapeutic reliability.
Key Specifications
-
Composition: * Pantoprazole Sodium IP: 40 mg (as gastro-resistant pellets)
-
Dosage Form: Hard Gelatin Capsules.
-
Manufacturing Standard: Manufactured by a WHO-GMP certified facility, ensuring rigorous adherence to global quality and safety benchmarks.
-
Therapeutic Profile: Designed for controlled release, ensuring sustained efficacy and consistent patient outcomes.
